China Universal China Universal Hang Seng H K - Listed Biotechnology Index ETF (SHA:513280)

Assets	n/a
Expense Ratio	0.20%
PE Ratio	17.34
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-10.43%

Volume	91,728,200
Open	1.191
Previous Close	1.186
Day's Range	1.170 - 1.197
52-Week Low	0.845
52-Week High	1.389
Beta	0.74
Holdings	33
Inception Date	May 7, 2022

About 513280

513280.SS was created on 2022-05-07 by China Universal. The fund's investment portfolio concentrates primarily on health care equity. Tightly track the target index, and pursue the minimization of tracking deviation and tracking error.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 513280
• Provider: China Universal
• Index Tracked: Hang Seng Biotech Index - HKD - Benchmark TR Gross

Performance

513280 had a total return of -10.43% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.84%.

Top 10 Holdings

68.68% of assets

Name	Symbol	Weight
BeOne Medicines AG	6160	10.03%
Innovent Biologics, Inc.	1801	10.03%
WuXi Biologics (Cayman) Inc.	2269	9.78%
WuXi AppTec Co., Ltd.	2359	8.31%
Akeso, Inc.	9926	7.23%
CSPC Pharmaceutical Group Limited	1093	6.27%
Sino Biopharmaceutical Limited	1177	5.07%
Hansoh Pharmaceutical Group Company Limited	3692	5.00%
3SBio Inc.	1530	3.82%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	6990	3.16%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error